← Leaderboards
Renumathy Dhanasekaran
Stanford University
$1,603,762
Attributed
$1,603,762
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $593K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,603,762 · 2
By mechanism
K08$1,010,720 · 1
R37$593,042 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- James D Brooks$12,828,912
- Sharon Pitteri$2,838,162
- Melanie Hayden Gephart$6,763,817
- Irving Lerner Weissman$56,491,773
- Thomas None Quertermous$63,279,401
Others in their field
Other Emerging Leaders on “Primary Carcinoma Of The Liver Cells”
- Amit Singal · Ut Southwestern Medical Center$15,537,004
- William H. Peranteau · Children'S Hosp Of Philadelphia$7,624,302
- Amaia Lujambio · Icahn School Of Medicine At Mount Sinai$5,368,450
- Valerian Nakaar · Carogen Corporation$4,718,929
- Cynthia A Moylan · Duke University$4,605,130
- Vera Hoffman · Reveal Pharma$4,535,285
Research focus
Primary Carcinoma Of The Liver CellsMalignant Neoplasm Of LiverIn VivoOverexpressionTumor ProgressionMouse ModelEnzyme-Linked Immunosorbent AssayIn VitroMalignant NeoplasmsNovel MarkerTissuesTumorPublic HealthNeoplasm MetastasisComplexCrispr/Cas TechnologyExperimental StudyInsightKnock-OutBiomarker IdentificationBaseCollectionAwardBiological Process
Grant awards (6)
Dysregulated Complement Pathway in Macrophage Reprogramming and Progression of HCC in MASH$593,042
R37 · FY2025 · CA · contact PI
Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)$202,144
K08 · FY2022 · CA · contact PI
Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)$202,144
K08 · FY2021 · CA · contact PI
Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)$202,144
K08 · FY2020 · CA · contact PI
Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)$202,144
K08 · FY2019 · CA · contact PI
Functional Proteomic Analysis and Biomarker Identification in a Novel Mouse Model of Metastatic Hepatocellular Carcinoma (HCC)$202,144
K08 · FY2018 · CA · contact PI